Multiple doctor-prescribed medications , including copyright and Semaglutide, are part of the GLP-1 receptor agonist group. Primarily , these drugs work by mimicking the body's own substances that control glucose levels and stimulate weight loss . Though copyright is a brand name for type 2 diab

Patients struggling with obesity are often faced with limited and sometimes ineffective treatment options. However, a groundbreaking new medication, Semaglutide, is rapidly changing the landscape of weight loss. Approved by regulatory bodies for chronic weight management, Semaglutide works as a